Omega Therapeutics Inc
NASDAQ:OMGA
Omega Therapeutics Inc
NASDAQ:OMGA
Price:
0.0485
USD
7.78%
Market Closed
Market Cap:
$2.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Omega Therapeutics Inc
NASDAQ:OMGA
|
US |
|
C
|
Capital Power Corp
OTC:CPXWF
|
CA |
|
Bengal Energy Ltd
OTC:BNGLF
|
CA |
|
Peak Minerals Ltd
ASX:PUA
|
AU |
|
Green Earth Group NV
AEX:EARTH
|
NL |
|
C
|
Cannlabs Inc
OTC:CANL
|
US |
|
D
|
Daesung Microbiological Labs Co Ltd
KOSDAQ:036480
|
KR |
Cash Flow Statement
Cash Flow Statement
Omega Therapeutics Inc
Omega Therapeutics Inc
Currency: USD
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||
| Net Income |
(29)
|
(38)
|
(47)
|
(57)
|
(68)
|
(75)
|
(85)
|
(93)
|
(103)
|
(108)
|
(112)
|
(108)
|
(97)
|
(92)
|
(79)
|
(73)
|
|
| Depreciation & Amortization |
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
1
|
2
|
2
|
2
|
2
|
2
|
|
| Stock-Based Compensation |
1
|
1
|
2
|
3
|
3
|
5
|
6
|
7
|
8
|
8
|
9
|
9
|
9
|
10
|
0
|
0
|
|
| Other Non-Cash Items |
1
|
1
|
2
|
4
|
5
|
7
|
10
|
10
|
13
|
13
|
13
|
13
|
14
|
15
|
13
|
14
|
|
| Cash Interest Paid |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Change in Working Capital |
1
|
4
|
3
|
2
|
5
|
(4)
|
(8)
|
(10)
|
(10)
|
(10)
|
(3)
|
(6)
|
(9)
|
0
|
(1)
|
2
|
|
| Cash from Operating Activities |
(26)
N/A
|
(31)
-18%
|
(40)
-30%
|
(50)
-25%
|
(58)
-15%
|
(70)
-22%
|
(82)
-16%
|
(90)
-10%
|
(99)
-9%
|
(103)
-5%
|
(100)
+3%
|
(99)
+2%
|
(92)
+7%
|
(75)
+18%
|
(65)
+14%
|
(56)
+14%
|
|
| Investing Cash Flow | |||||||||||||||||
| Capital Expenditures |
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(2)
|
|
| Other Items |
0
|
0
|
0
|
0
|
(39)
|
(96)
|
(84)
|
(74)
|
(17)
|
63
|
76
|
65
|
50
|
33
|
8
|
8
|
|
| Cash from Investing Activities |
(2)
N/A
|
(2)
+1%
|
(2)
-39%
|
(2)
+28%
|
(40)
-2 157%
|
(98)
-142%
|
(86)
+12%
|
(75)
+13%
|
(18)
+76%
|
62
N/A
|
74
+21%
|
63
-15%
|
48
-25%
|
30
-37%
|
5
-82%
|
6
+13%
|
|
| Financing Cash Flow | |||||||||||||||||
| Net Issuance of Common Stock |
49
|
138
|
133
|
255
|
254
|
128
|
128
|
(1)
|
1
|
41
|
41
|
41
|
40
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
8
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
(1)
|
(2)
|
|
| Other |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
|
| Cash from Financing Activities |
49
N/A
|
138
+184%
|
133
-4%
|
254
+91%
|
262
+3%
|
136
-48%
|
136
0%
|
7
-95%
|
1
-90%
|
41
+5 621%
|
41
+0%
|
41
0%
|
42
+3%
|
1
-98%
|
(1)
N/A
|
(2)
-252%
|
|
| Change in Cash | |||||||||||||||||
| Net Change in Cash |
21
N/A
|
105
+409%
|
91
-14%
|
203
+124%
|
164
-19%
|
(32)
N/A
|
(32)
+2%
|
(158)
-400%
|
(116)
+27%
|
(1)
+99%
|
15
N/A
|
5
-65%
|
(2)
N/A
|
(45)
-1 949%
|
(60)
-34%
|
(51)
+14%
|
|
| Free Cash Flow | |||||||||||||||||
| Free Cash Flow |
(28)
N/A
|
(33)
-17%
|
(43)
-30%
|
(52)
-22%
|
(59)
-14%
|
(72)
-22%
|
(83)
-16%
|
(92)
-10%
|
(100)
-9%
|
(105)
-5%
|
(102)
+2%
|
(101)
+1%
|
(94)
+6%
|
(79)
+17%
|
(67)
+14%
|
(58)
+14%
|
|
Switch to:
Switch to:
See Also
Discover More
